Scaling Functional Medicine
This month, we look at the future of how Functional Medicine can scale to meet the needs or modern health systems outside of America. The first hour we'll connect and network with the thriving functional community in Denver. Then, we'll tap into the live stream of the Global Functional Forum from the Royal Society of Medicine in London, the world’s oldest medical institution.
First, Dr. Rangan Chatterjee speaks to his experience on a unique 3 program series on BBC1 in 2015: Doctor in the House. This series looked at how an NHS GP could immerse himself with three families to guide them back to health using the principles and practices of functional medicine. One of the highlights was reversing the diagnosis of type 2 diabetes in just 6 weeks.
Next, James Maskell explains how modern practices are using innovations in delivery models, care teams, and digital technology to reduce overhead, appointment times, and systemic costs. With news that some of the most innovative health centers like the Cleveland Clinic are betting on Functional Medicine as a superior operating system for chronic disease care, what can Britain learn from America’s early lessons in delivery to make this a viable option for the NHS and other major health systems?
Michael Ash, DO speaks to the how we can no longer place the simplistic notion of ‘bad’ against bacteria, yeasts and viruses, many it seems can qualify in an equally simplistic notion as being ‘good’. In part, our natural instinct to simplify risk or benefit does us a disservice as the relationship between humans and their extensive microbiome is co-dependent on the external environment, the state of the human health, immune plasticity, age, diet, geography, income and other factors.
Dr. Rangan Chatterjee, MBChB, BSc (Hons), MRCGP, MRCP
“Functional Medicine – the NHS perspective”
James Maskell, Founder of Functional Forum
“Lessons from America in Scaling Functional Medicine”
Michael Ash,DO, ND, BSc, RNT
“The forgotten organ: why our guts biome is reversing the ‘germ theory’ domination of medicine, and why it’s relevant for NCDs.”